The Royal Wolverhampton Hospital NHS Trust
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Clinical Trials
43
Active:2
Completed:28
Trial Phases
3 Phases
Phase 3:1
Phase 4:2
Not Applicable:13
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
13 (81.3%)Phase 4
2 (12.5%)Phase 3
1 (6.3%)IBDminds - Mapping the Influence of aNxiety and DepreSsion on IBD
Not yet recruiting
- Conditions
- Inflammatory Bowel DiseasesMental Health Issue
- First Posted Date
- 2025-09-16
- Last Posted Date
- 2025-09-22
- Lead Sponsor
- The Royal Wolverhampton Hospitals NHS Trust
- Target Recruit Count
- 450
- Registration Number
- NCT07175454
- Locations
- π¬π§
The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom
Cost-effectiveness Analyses for the Prevention of Acute Kidney Injury in Patients Undergoing Cardiac Surgery in the UK
Not yet recruiting
- Conditions
- Acute Kidney Injury
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- The Royal Wolverhampton Hospitals NHS Trust
- Target Recruit Count
- 8000
- Registration Number
- NCT07108634
- Locations
- π¬π§
New Cross Hospital, Wolverhampton, West Midlands, United Kingdom
Artificial Intelligence for Reconstruction of Echocardiography Studies
Not yet recruiting
- Conditions
- Cardiotoxicity
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- The Royal Wolverhampton Hospitals NHS Trust
- Target Recruit Count
- 120
- Registration Number
- NCT07093918
Albert Health App PEG Study
Not yet recruiting
- Conditions
- Feeding Tube Complication
- First Posted Date
- 2025-01-13
- Last Posted Date
- 2025-09-10
- Lead Sponsor
- The Royal Wolverhampton Hospitals NHS Trust
- Target Recruit Count
- 50
- Registration Number
- NCT06772285
- Locations
- π¬π§
The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom
Serum GFAP and UCHL1: Evaluation of Their Predictive Value for SAH
Terminated
- Conditions
- Subarachnoid Haemorrhage (SAH)
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- The Royal Wolverhampton Hospitals NHS Trust
- Target Recruit Count
- 144
- Registration Number
- NCT06581757
- Locations
- π¬π§
New Cross Hospital, Wolverhampton, West Midlands, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
No news found